A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers-Reference-Cited by-同舟云学术

A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers

Published:2007-10-10 Issue:10 Volume:2 Page:e1018
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Genton Blaise,Pluschke Gerd,Degen Lukas,Kammer Andreas R.,Westerfeld Nicole,Okitsu Shinji L.,Schroller Sandro,Vounatsou Penelope,Mueller Markus M.,Tanner Marcel,Zurbriggen Rinaldo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.;TC Luke;J Exp Biol,2003

2. Vaccine-induced immunity to malaria parasites and the need for novel strategies.;MF Good;Trends Parasitol,2005

3. Exploiting conformationally constrained peptidomimetics and an efficient human-compatible delivery system in synthetic vaccine design.;R Moreno;Chembiochem,2001

4. Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1.;MS Mueller;Infect Immun,2003

5. A virosome-mimotope approach to synthetic vaccine design and optimization: synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate.;B Pfeiffer;Angew Chem Int Ed Engl,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capillary electrophoresis in the analysis of therapeutic peptides—A review;ELECTROPHORESIS;2023-09-14

2. A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge;Scientific Reports;2023-03-28

3. Peptides for Vaccine Development;ACS Applied Bio Materials;2022-02-23

4. Nanovaccine: an emerging strategy;Expert Review of Vaccines;2021-09-29

5. Nanotechnological immunoassay for rapid label-free analysis of candidate malaria vaccines;Nanoscale;2021